1 / 6
Laboratory Research Material
TB-500 5mg
- Compound
- TB-500
- Amount per vial
- 5 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Product Documentation
Details, specifications, and reviews
Description
TB-500 5 mg
Buy TB-500 5 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.
It is a single-compound product, separate from blends that combine TB-500 with other ingredients.
The TB-500 supplied in this product is full-length, N-acetylated thymosin beta-4: a 43-amino-acid peptide identified by CAS 77591-33-4.
Choose the amount and formulation
The alternative TB-500 10 mg listing is available for comparison. Check the product and batch records for the selected size; a larger labeled amount does not establish different purity or a different research effect.
On a blend listing, the total amount includes more than one compound. Compare its composition and individual amounts rather than treating the blend total as the quantity of TB-500. This powder listing is also a different presentation from a capsule, spray or prepared solution.
TB-500 and thymosin beta-4
This listing uses the full-length thymosin beta-4 identity. The terminal form is N-acetylated with a free-acid C-terminus; its reference sequence contains 43 amino acids.
A 2012 analytical study identified a different, acetylated seven-residue fragment in the preparation it examined. That fragment study explains why the TB-500 name alone is insufficient when comparing products or experimental methods. It does not characterize the full-length material listed here.
Match the documentation to the vial
Open COA & Documents to review the available product files and batch reports. For a sequence-specific experiment, match the full-length reference identity above to the experimental method. Lot reports provide separate evidence about the tested sample and the measurements performed.
Check the report’s product and lot, the methods performed, and whether each result concerns identity, chromatographic purity or measured content. Keep the 5 mg label separate from any measured batch result. The 3 mL container capacity is not a solution concentration or an instruction to add that volume of solvent.
Use handling and storage information applicable to the supplied material and laboratory method. Fixed preparation conditions or biological claims taken from another supplier’s product do not establish those properties for this vial.
Additional information
| CAS No. | 77591-33-4 |
|---|---|
| Purity | ≥99% |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Independent lot testing
TB-500 5mg Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 42601
- Report number
- IF-824-QSA-TR006-2026-127-58
- Date tested
- March 2, 2026
- Reported purity
- 99.1%
- Labeled content
- 5 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for TB-500 5mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Only logged in customers who have purchased this product may leave a review.
Need Assistance?
Questions about product documentation?
Our support team can assist with product records, lot information, order questions, and certificate verification.

There are no reviews yet.